Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions

[1] Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (03) : 353 - 362

[2] Effect of hepatic impairment on the multiple-dose pharmacokinetics of ranolazine sustained-release tablets [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (07) : 802 - 809

[3] Effects of ranolazine on L-type calcium channel currents in guinea-pig single ventricular myocytes [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) : 249 - 254

[4] Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties [J]. CIRCULATION, 2004, 110 (08) : 904 - 910

[5] Antzelevitch Charles, 2004, Journal of Cardiovascular Pharmacology and Therapeutics, V9, pS65, DOI 10.1177/107424840400900106

[6] Effects of ranolazine on ischemic threshold, coronary sinus blood flow, and myocardial metabolism in coronary artery disease [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (03) : 479 - 484

[7] Inhibition of late (sustained/persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2004, 6 (0I) : I3 - I7

[8] Intracellular Na+ regulation in cardiac myocytes [J]. CARDIOVASCULAR RESEARCH, 2003, 57 (04) : 897 - 912

[9] Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina -: A randomized, double-blind, multicentered, placebo-controlled trial [J]. CIRCULATION, 2003, 107 (06) : 817 - 823

[10] Chaitman Bernard R, 2002, Curr Probl Cardiol, V27, P527

[1] Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (03) : 353 - 362

[2] Effect of hepatic impairment on the multiple-dose pharmacokinetics of ranolazine sustained-release tablets [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (07) : 802 - 809

[3] Effects of ranolazine on L-type calcium channel currents in guinea-pig single ventricular myocytes [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) : 249 - 254

[4] Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties [J]. CIRCULATION, 2004, 110 (08) : 904 - 910

[5] Antzelevitch Charles, 2004, Journal of Cardiovascular Pharmacology and Therapeutics, V9, pS65, DOI 10.1177/107424840400900106

[6] Effects of ranolazine on ischemic threshold, coronary sinus blood flow, and myocardial metabolism in coronary artery disease [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (03) : 479 - 484

[7] Inhibition of late (sustained/persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2004, 6 (0I) : I3 - I7

[8] Intracellular Na+ regulation in cardiac myocytes [J]. CARDIOVASCULAR RESEARCH, 2003, 57 (04) : 897 - 912

[9] Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina -: A randomized, double-blind, multicentered, placebo-controlled trial [J]. CIRCULATION, 2003, 107 (06) : 817 - 823

[10] Chaitman Bernard R, 2002, Curr Probl Cardiol, V27, P527